There may be a clearer tomorrow,
starting today

Most people were clear or almost clear with just 2 doses (at 12 weeks). That means fewer symptoms like plaques, redness, and flakes. All with dosing every 12 weeks—only 4 doses a year—after 2 initial doses.

Individual results may vary.

START RIGHT WITH ILUMYA™

Watch the ILUMYA™ commercial

LASTING RESULTS

Studies showed that 6 out of 10 people were clear or almost clear after 2 doses of ILUMYA™ and continued to clear over time.

Individual results may vary.

WHAT TO EXPECT

FEWER DOSES

After your 2 initial doses, ILUMYA™ is given to you every 12 weeks by your dermatologist—just 4 doses a year.

DISCOVER DOSING
WITH ILUMYA™

How ILUMYA™ works differently

ILUMYA™ is a biologic medicine. Biologics like ILUMYA™ target a specific part of the immune system and block the molecules that make psoriasis worse.

Learn how ILUMYA™
is different

ILUMYA™ is not for everyone. Ask your doctor if ILUMYA™ could be the treatment you’re looking for.

Start your journey off right

To get the most out of treatment, enroll in ILUMYA SUPPORT Lighting the Way™. Our support team is ready to help you get started.

GET STARTED

Support to keep you going

Make sure to enroll in ILUMYA SUPPORT Lighting the Way™, and see if you’re eligible to receive ILUMYA™ at low or no cost.

Get the benefits
YOU GET MORE INFORMATION.
WE MAKE A DONATION.

Here's your chance to get help finding your next treatment while also helping other psoriasis patients. By signing up, you receive more information about ILUMYA™ and how it may be the treatment option for you. As a thank you for signing up, Sun Pharma will donate $5 to the National Psoriasis Foundation® (NPF) on your behalf. This donation will help support the NPF's mission to drive efforts to cure psoriatic disease and improve the lives of those affected.

National Psoriasis Foundation
All fields required.

By clicking the Submit button, I authorize Sun Pharmaceutical Industries, Inc., its affiliates, subsidiaries, and third-party agents to contact me by mail and/or email to provide information on dermatology products, programs, services, and disease-state information and/or utilize my information for market research or analytics. Sun Pharmaceutical Industries, Inc., its affiliates, subsidiaries, and third-party agents will not utilize or distribute my personal information outside the above terms of consent.

Please refer to our Privacy Policy for more information.